NCT06054347 (EPIDEV-B6) is a clinical trial of VINELAND II in Pyridoxine-Dependent Epilepsy, sponsored by University Hospital, Angers.

Who is sponsoring NCT06054347?

NCT06054347 is sponsored by University Hospital, Angers.

What drugs are being tested in NCT06054347?

Interventions in NCT06054347: VINELAND II.

What condition does NCT06054347 study?

NCT06054347 studies Pyridoxine-Dependent Epilepsy.

Is NCT06054347 still recruiting?

NCT06054347 is currently completed. Last updated 11 August 2025.

Last reviewed 2025-08-11 · How we verify

NCT06054347: EPIDEV-B6

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy

Completed Last updated 11 August 2025

What this trial tests

trial testing VINELAND II in Pyridoxine-Dependent Epilepsy in 30 participants. Completed in 21 May 2025.

Timeline

29 December 2023

Primary endpoint
21 May 2025

21 May 2025

Quick facts

Lead sponsor	University Hospital, Angers
Status	Completed
Study type	OBSERVATIONAL
Enrollment	30
Start date	29 December 2023
Primary completion	21 May 2025
Estimated completion	21 May 2025
Sites	12 locations across France

Drugs / interventions tested

VINELAND II

Conditions studied

Pyridoxine-Dependent Epilepsy — all drugs for Pyridoxine-Dependent Epilepsy →

Sponsor

University Hospital, Angers

Who can join

3 and older, any sex, with Pyridoxine-Dependent Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate with the VINELAND II scale the long-term neurocognitive development of children above age 3 years with pyridoxine dependent epilepsy related to antiquitine deficiency.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Angers trials

Trials by the same sponsor.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07470294 — Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Popula · not yet recruiting
NCT07409597 — Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease · NA · not yet recruiting
NCT07468565 — Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) · not yet recruiting
NCT07452952 — Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distre · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06054347 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Angers
Last refreshed: 11 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06054347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing